NLRP3 and Hypoglycemia: Glyburide is used in clinic for diabetic treatment, the dose for its NLRP3 inflammasome inhibition effects is at the risk of inducing hypoglycemia, thus cannot be used directly as NLRP3 inhibitor [15].